Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

9.28

+0.1(+1.09%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap6.34B
Enterprise Value7.09B
P/E Ratio-48.09
PEG Ratio9.14
Price/Sales Ratio2.5
Price/Book Ratio5.16
Enterprise/Revenue2.99
Enterprise/EBITDA-187.29

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.05
Operating Margin-0.07

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.08

Income Statement

Revenue1.41B
Revenue/Share3.63
Gross Profit676.44M
EBITDA-159.6M
Net Income-274.46M
Diluted EPS-0.69

Balance Sheet

Total Cash162.07M
Total Cash/Share0.44
Total Debt886.13M
Total Debt/Equity1.22
Current Ratio0.84
Book Value Per Share1.89

Price History

52-Week Change-13.44
52-Week High25.16
52-Week Low8.18
Moving Average 50 Days9.16
Moving Average 200 Days13.8

Statistics

Average Volume7.05M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.18
Last Split FactorN/A
Last Split DateN/A